Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.

Item
http://www.wikidata.org/entity/Q36203104
Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice.Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytesAdenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarctionCardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of respiratory disease.Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.Role of phosphodiesterase 5 in synaptic plasticity and memoryToday's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?Regulation of injury-induced neurogenesis by nitric oxide.Treatment of obstructive airway diseases with roflumilast, a novel phosphodiesterase 4 inhibitor.Small RNA-seq during acute maximal exercise reveal RNAs involved in vascular inflammation and cardiometabolic health: brief report.
P2860

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.

Item
http://www.wikidata.org/entity/Q36203104
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
@ast
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
@en
type
label
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
@ast
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
@en
prefLabel
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
@ast
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921